Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AHCL Anlon Healthcare Limited Pharma · Small | BAFNAPH Bafna Pharmaceuticals Limited Pharma · Small | AMANTA Amanta Healthcare Limited Pharma · Small | KOPRAN Kopran Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 55 | 33 | 39 | 26 |
| Verdict | FAIR VALUE | WATCHLIST | WATCHLIST | OVERVALUED |
| Style | FAIR_VALUE | WATCHLIST | WATCHLIST | OVERVALUED |
| Piotroski | 6/9 | 8/9 | 6/9 | 7/9 |
| Valuation | 10/30 | 5/30 | 6/30 | 4/30 |
| Growth | 21/25 | 10/25 | 19/25 | 3/25 |
| Quality | 11/20 | 2/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 10/15 | 7/15 | 10/15 |
| Cash Flow | 0/10 | 4/10 | 4/10 | 4/10 |
| Price | ₹15.06 | ₹165.45 | ₹151.82 | ₹181.64 |
| P/E | 28.10 | 35.30 | 35.90 | 34.10 |
| P/B | 3.49 | 4.06 | 2.68 | 1.65 |
| ROE | 18.40% | 12.30% | 10.40% | 4.91% |
| ROCE | 20.80% | 11.90% | 11.60% | 6.65% |
| Debt / Equity | 0.19 | 0.39 | 1.11 | 0.29 |
| FCF Yield | — | — | — | 0.23% |
| Dividend Y | — | — | — | 1.65% |
| Altman Z | 5.10 | 4.86 | 2.51 | 3.32 |
| Promoter % | 52.68% | 75.00% | 63.72% | 44.43% |
| Mkt Cap (₹Cr) | 800.00 | 391.00 | 590.00 | 877.00 |
| Graham # | ₹7.25 | ₹65.45 | ₹69.9 | ₹114.86 |
| Fair PE | 42.0 | 42.0 | 42.0 | 2.9 |
| MoS % | +33.6% | +16.0% | +5.6% | -1059.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAHCL16
BAFNAPH201
AMANTA109
KOPRAN59